Diabetes
Conference Coverage
Data build on cardiovascular disease risk after GDM, HDP
WASHINGTON – “The metabolic stress of pregnancy can uncover underlying susceptibilities.” – Deborah B. Ehrenthal, MD...
Conference Coverage
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –
Latest News
FDA panel rejects new empagliflozin indication for type 1 diabetes
Panelists voted 14-2 against the application and criticized the limited data supporting the application.
Conference Coverage
New model for CKD risk draws on clinical, demographic factors
The equation has demonstrated high discrimination and variable calibration across a range of populations.
From the Journals
Vitamin D, omega-3 fatty acids do not preserve kidney function in type 2 diabetes
After 5 years of follow-up, the supplements showed no significant difference in change in eGFR, compared with placebo.
Commentary
It’s time to get to know AI
Artificial intelligence will be widely deployed in clinical tools that improve our diagnostic accuracy and provide better personalized data to...
Applied Evidence
An FP’s guide to AI-enabled clinical decision support
To better understand the capabilities and challenges of artificial intelligence and machine learning, we look at the role they can play in...
Latest News
Cardiometabolic risk burden is high in under-50s with type 2 diabetes
BARCELONA – Younger people with type 2 diabetes need a more focused treatment strategy, irrespective of cardiometabolic risk.
Applied Evidence
How to use type 2 diabetes meds to lower CV disease risk
The challenge: Translate evidence from cardiovascular outcomes trials of newer antidiabetic agents into a targeted management strategy.
Latest News
Ketoacidosis is on the rise in children with type 1 diabetes
BARCELONA – Data highlight an increase in prevalence at diagnosis, but certain factors may help identify those most at risk.
Latest News
Signs of adult diabetes apparent in very young children
BARCELONA – Disturbed HDL cholesterol metabolism may be one of the earliest features of type 2 diabetes.